Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kenemans

Showing results (121-130 of 235) with videos related to

Pageof 24
Sort By:
Clinical Chemistry|March 1, 1997
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference valueJ M Bonfrer, C M Korse, R A Verstraeten, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 12, 2004
Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal womenR G V Smolders, K de Meer, P Kenemans, et al.
Cancer|December 24, 1997
Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I studyC F Molthoff, H M Prinssen, P Kenemans, et al.
Obstetrics and Gynecology|March 10, 1998
A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal womenV Mijatovic, P Kenemans, C Jakobs, et al.
European Heart Journal|May 1, 1996
Hormone replacement therapy: a useful tool in the prevention of coronary artery disease in postmenopausal women? Working Group on Women and Cardiovascular Disease of The Netherlands Heart FoundationC J Moerman, J C Witteman, H J Collette, et al.
British Journal of Cancer|June 1, 1993
CA 125 half-life in ovarian cancer: a multivariate survival analysisC A Yedema, P Kenemans, F Voorhorst, et al.
Thrombosis and Haemostasis|July 15, 1999
Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal womenW M van Baal, P Kenemans, M J van der Mooren, et al.
Oncogene|November 1, 1993
MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpressionF V Cromme, P J Snijders, A J van den Brule, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 13, 2001
Ultrasound assessment of the endometrium in healthy, asymptomatic early post-menopausal women: saline infusion sonohysterography versus transvaginal ultrasoundS J Neele, W Marchien van Baal, M J van der Mooren, et al.
International Journal of Cancer|April 21, 1995
Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristicsM R Buist, P Kenemans, C F Molthoff, et al.
Pageof 24

Showing results (121-130 of 235) with videos related to

Sort By:
Pageof 24
Clinical Chemistry|March 1, 1997
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference valueJ M Bonfrer, C M Korse, R A Verstraeten, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 12, 2004
Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal womenR G V Smolders, K de Meer, P Kenemans, et al.
Cancer|December 24, 1997
Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I studyC F Molthoff, H M Prinssen, P Kenemans, et al.
Obstetrics and Gynecology|March 10, 1998
A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal womenV Mijatovic, P Kenemans, C Jakobs, et al.
European Heart Journal|May 1, 1996
Hormone replacement therapy: a useful tool in the prevention of coronary artery disease in postmenopausal women? Working Group on Women and Cardiovascular Disease of The Netherlands Heart FoundationC J Moerman, J C Witteman, H J Collette, et al.
British Journal of Cancer|June 1, 1993
CA 125 half-life in ovarian cancer: a multivariate survival analysisC A Yedema, P Kenemans, F Voorhorst, et al.
Thrombosis and Haemostasis|July 15, 1999
Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal womenW M van Baal, P Kenemans, M J van der Mooren, et al.
Oncogene|November 1, 1993
MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpressionF V Cromme, P J Snijders, A J van den Brule, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 13, 2001
Ultrasound assessment of the endometrium in healthy, asymptomatic early post-menopausal women: saline infusion sonohysterography versus transvaginal ultrasoundS J Neele, W Marchien van Baal, M J van der Mooren, et al.
International Journal of Cancer|April 21, 1995
Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristicsM R Buist, P Kenemans, C F Molthoff, et al.
Pageof 24